The conference will cover major research topics as listed below but are not limited to:
Blood infectious diseases are illnesses that impact the bloodstream, such as sepsis, HIV, and hepatitis B or C. These infections can rapidly circulate throughout the body, often causing systemic symptoms and requiring immediate medical attention to prevent serious complications or death. These diseases pose major global health challenges due to their potential for chronic illness and transmission via transfusion or intravenous drug use. This session explores advances in blood screening, viral load monitoring, and emerging therapies.
Mycology is the scientific study of fungi, including both their beneficial and harmful roles in human health. Medical mycology focuses on identifying and treating fungal infections like candidiasis, aspergillosis, and histoplasmosis, especially in immunocompromised patients. With rising antifungal resistance and limited treatment options, this session highlights current research in fungal pathogenesis, diagnostics, epidemiology, and novel antifungal agents.
Sexually Transmitted Infections including HIV/AIDS, gonorrhea, syphilis, and chlamydia, affect millions globally. HIV/AIDS targets the immune system, leading to chronic immune suppression, while other STIs can cause reproductive health issues and increase HIV transmission risk. This session examines the global burden, evolving transmission patterns, and innovative prevention and treatment strategies for sexually transmitted infections, with an emphasis on HIV/AIDS.
Neglected Tropical Diseases (NTDs) are a group of infections that primarily affect impoverished communities in tropical and subtropical regions. Diseases such as leishmaniasis, Chagas disease, and lymphatic filariasis lead to chronic disability and are often overlooked in global health priorities despite their large burden. These diseases primarily affect populations in low-income regions and have historically received limited research funding. This session addresses parasitic, viral, and bacterial NTDs such as leishmaniasis, trachoma, and lymphatic filariasis, highlighting progress toward eradication and the role of One Health approaches.
This field focuses on viruses microscopic agents that infect living cells. Common viral diseases include influenza, COVID-19, and hepatitis. Virology investigates viral structure, replication, pathogenesis, and develops diagnostics, vaccines, and treatments. This session includes cutting-edge research on viral evolution, host interactions, immune evasion, and vaccine development, as well as surveillance systems for viral outbreaks.
AMR is a critical global health threat where microbes evolve to resist drugs that once killed them. Misuse and overuse of antibiotics and antifungals accelerate resistance, leading to harder-to-treat infections, longer hospital stays, and higher mortality. This session explores the crisis of increasing resistance to antibiotics, antifungals, and antivirals and discussions focus on the mechanisms of resistance, the global policy response, and innovations in diagnostics and therapeutics to combat AMR across human, animal, and environmental health sectors.
These infections result from pathogenic bacteria or fungi. They can cause a wide range of diseases, from mild skin infections to life-threatening systemic illnesses. This session addresses clinical management, diagnostics, pathogen genomics, and resistance trends.
IPC involves measures designed to reduce the risk of spreading infections in healthcare and community settings. These include hand hygiene, sterilization practices, isolation precautions, and surveillance to detect and contain outbreaks early. IPC remains a cornerstone of public health and clinical care. This session emphasizes hospital protocols, outbreak containment, disinfection strategies, and global standards for reducing healthcare-associated infections and improving safety in clinical environments.
Rare infectious diseases, such as prion diseases, Ebola, and Marburg virus, are uncommon but can be highly lethal. They often require specialized diagnosis, treatment, and containment strategies due to their high transmission risk and limited therapeutic options. This session focuses on low-incidence but high-impact infections that are often overlooked in mainstream research.
This area studies how the immune system detects and eliminates pathogens, and how the resulting inflammatory response can protect or harm the host. Chronic inflammation from infections can lead to tissue damage and long-term health issues.
These diseases arise from consuming contaminated food or water and include cholera, typhoid, and norovirus. Poor sanitation and unsafe food handling are major contributors, often leading to large-scale outbreaks, particularly in developing regions. This session covers global outbreaks, food safety systems, water sanitation initiatives, and microbial risk assessments for prevention and control.
This topic examines how anti-infective drugs interact with the body and pathogens. It includes drug mechanisms, absorption, resistance patterns, dosing strategies, and side effects to ensure effective and safe treatment of infectious diseases.
Innovative therapies aim to address the limitations of current treatments by developing new antimicrobials, antivirals, immunotherapies, and vaccines. Drug discovery involves identifying new targets, testing compounds, and bringing effective therapies to market. This session highlights new strategies for discovering and developing treatments for infectious diseases.